Len Pagliaro

Chief Executive Officer at Siva Therapeutics, Inc.

Commercial Services

Profile

Len Pagliaro is the founder of Siva Therapeutics, Inc. He is currently the President & Chief Executive Officer of the company, a position he has held since its founding in 2010.

Len Pagliaro active positions

Companies	Position	Start
Siva Therapeutics, Inc. Siva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sona Nanotech, Inc., Siva Therapeutics, Inc. is a company that aims to develop less invasive, safer, more effective, less costly, and more practical cancer therapies than current treatments on the market. The company is based in Denver, CO. Siva Therapeutics is developing Targeted Hyperthermia™ (THT), a cancer therapy that generates therapeutic heat within solid tumors using Sivaro™ gold nanorods and a Sivalum™ infrared light device. This treatment promises to be minimally invasive, reduce harmful side effects, and stimulate the immune system. The company was founded in 2010 by Steve Kregstein, Len Pagliaro, and Len Pagliaro has been the CEO since 2010. Siva Therapeutics was acquired by Sona Nanotech, Inc. on March 23, 2023 for $8.65 million.	Chief Executive Officer	21/10/2010

All active positions of Len Pagliaro

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Len Pagliaro's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Siva Therapeutics, Inc. Siva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sona Nanotech, Inc., Siva Therapeutics, Inc. is a company that aims to develop less invasive, safer, more effective, less costly, and more practical cancer therapies than current treatments on the market. The company is based in Denver, CO. Siva Therapeutics is developing Targeted Hyperthermia™ (THT), a cancer therapy that generates therapeutic heat within solid tumors using Sivaro™ gold nanorods and a Sivalum™ infrared light device. This treatment promises to be minimally invasive, reduce harmful side effects, and stimulate the immune system. The company was founded in 2010 by Steve Kregstein, Len Pagliaro, and Len Pagliaro has been the CEO since 2010. Siva Therapeutics was acquired by Sona Nanotech, Inc. on March 23, 2023 for $8.65 million.	Commercial Services